Cargando…
Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness
BACKGROUND: Post-therapeutic follow-up is essential to confirm cure and to detect early treatment failures in patients affected by sleeping sickness (HAT). Current methods, based on finding of parasites in blood and cerebrospinal fluid (CSF) and counting of white blood cells (WBC) in CSF, are imperf...
Autores principales: | Tiberti, Natalia, Lejon, Veerle, Hainard, Alexandre, Courtioux, Bertrand, Robin, Xavier, Turck, Natacha, Kristensson, Krister, Matovu, Enock, Enyaru, John Charles, Mumba Ngoyi, Dieudonné, Krishna, Sanjeev, Bisser, Sylvie, Ndung′u, Joseph Mathu, Büscher, Philippe, Sanchez, Jean-Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585011/ https://www.ncbi.nlm.nih.gov/pubmed/23469311 http://dx.doi.org/10.1371/journal.pntd.0002088 |
Ejemplares similares
-
Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness
por: Tiberti, Natalia, et al.
Publicado: (2012) -
New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients
por: Tiberti, Natalia, et al.
Publicado: (2013) -
Neopterin and CXCL-13 in Diagnosis and Follow-Up of Trypanosoma brucei gambiense Sleeping Sickness: Lessons from the Field in Angola
por: Bonnet, Julien, et al.
Publicado: (2019) -
A Combined CXCL10, CXCL8 and H-FABP Panel for the Staging of Human African Trypanosomiasis Patients
por: Hainard, Alexandre, et al.
Publicado: (2009) -
Target product profile: diagnostic test for Trypanosoma brucei gambiense
por: Priotto, Gerardo, et al.
Publicado: (2023)